Another type of test coming out of the genomic revolution involves looking at individual genetic mutations that are known to be associated with specific medical consequences.

FORBES: Why Personalized Medicine Is Bunk

The genomic revolution is simply providing us with more things to measure, but only a very small fraction of these are medically meaningful and can be turned into new diagnostics.

FORBES: Why Personalized Medicine Is Bunk

Schroer's fund, invested largely in pharmaceuticals and biotech, is up 35% so far this year on the strength of some good venture-capital investments and investor excitement over the potential genomic revolution.

FORBES: Genes, Drugs And Demographics